Alten

25/10/24 -"We have revised our estimates on Alten following the release of its Q3 sales figures and the subsequent profit warning. We now anticipate a 2% organic sales decline in FY25 (vs. 1% organic growth ..."

PDF page sample
Pages
57
Language
English
Published on
25/10/24
Download
You may also be interested by these reports :
19/05/25
2Q24/25 preview: Sequentially improving margins expected
16/05/25
Atos has unveiled ambitious financial targets for 2028, alongside a new strategic plan aimed at reigniting organic growth, restoring operating ...
12/05/25
Improving operating momentum from 2H25 on expected
08/05/25
Public sector headwind expected to ease in 2H25 and likely turns into a tailwind from 2026 on

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO